N/A
Completed N=24
High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy
Rotator Cuff Tendinosis
Source: ClinicalTrials.gov NCT05483517 ↗
Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcomePrimary: Change in Pain Visual Analogue Scale(VAS) — 5.91; 5.90; 4.73; 4.60 score on a scale
Summary
The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Visual Analogue Scale(VAS) |
5.91; 5.90; 4.73; 4.60; 3.55; 4.90 | — |
| SECONDARY Change in Total Score of Shoulder Pain and Disability Index (SPADI) |
58.27; 65.80; 39.18; 52.40; 41.27; 60.20 | — |
| SECONDARY Changes of Shoulder Range of Motion in Active Flexion |
143.74; 154.11; 147.76; 152.53; 144.89; 149.79 | — |
| SECONDARY Changes of Shoulder Range of Motion in Active Abduction |
142.51; 153.79; 147.16; 154.22; 152.93; 153.00 | — |
| SECONDARY Changes of Shoulder Range of Motion in Active Internal Rotation |
60.75; 73.03; 68.46; 73.33; 71.19; 80.94 | — |
Eligibility Criteria
Inclusion Criteria
- age between 20 to 75 years old
- persistent shoulder pain for at least 3 months and pain VAS score >=5
- positive result in any of the following physical examinations: Hawkins-Kennedy, Neer or Jobe tests
- confirmed rotator cuff tendinopathy by ultrasonography or MRI
Exclusion Criteria
- complete or full-thickness tear of rotator cuff found by ultrasonography or MRI
- previous shoulder surgery
- previous history of severe trauma in shoulder
- cervical radiculopathy related shoulder pain or referred pain
- other shoulder diseases: adhesive capsulitis, calcifying tendinopathy, radiology-confirmed acromion type III, shoulder instability, degenerative osteoarthritis, labral tear
- present with any of the following systemic diseases: active infection, sever and uncontrolled medical condition, cancer, immune-related or rheumatoid arthritis, hyperuricemia and gout
- previous treatment with articular or subacromial steroid injections within the last 3 months
- cognitive impairment with loss of ability to sign the agreement and receive rehabilitation
- pregnancy or lactating women
- has any of the following contraindications: Carriers of pacemakers, internal defibrillators,internal metal implants (locally dependent), Cochlea implants, metallic stents, insulin pumps
Data sourced from ClinicalTrials.gov (NCT05483517). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.